Clinical Trial Market Research Reports & Industry Analysis

• Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More

• Gaucher's disease - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gaucher's disease Understanding The DelveInsight Gaucher's disease ... Read More

• Mouth Neoplasms - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Mouth Neoplasms Understanding The DelveInsight Mouth Neoplasms ... Read More

• Gender dysphoria - Epidemiology Insight - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gender dysphoria Understanding The DelveInsight Gender dysphoria ... Read More

• Acute Ocular Pain (AOP) - Epidemiology Forecast to 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Acute Ocular Pain ... Read More

• Chemotherapy-induced nausea and vomiting (CINV) - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Chemotherapy-induced ... Read More

• Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Malignant Pleural Mesothelioma Understanding The ... Read More

• Pollen Allergy - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  ... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Pollen Allergy Understanding The DelveInsight Pollen Allergy ... Read More

• SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026

  Mar 01, 2021  |  Published by: Kelly Scientific Publications  |  USD 4,900

  ... and the vast potential of vaccines that are in clinical trials. Kelly Scientific analysis indicates that the global COVID vaccine market was worth $59 billion in 2021. However, our forecast indicates that an initial drop ... Read More

• Vaccines 2020: World Market Analysis, Players, Trends

  Dec 07, 2020  |  Published by: Kalorama Information  |  USD 4,000

  ... vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. The report also discusses trends and looks at what ... Read More

• Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

  Apr 20, 2020  |  Published by: Kalorama Information  |  USD 6,000

  ... push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, ... Read More

• Blockchain Technologies in Healthcare

  Nov 22, 2019  |  Published by: Kalorama Information  |  USD 2,000

  ... it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain Technologies ... Read More

• Global Clinical Trials - Current Trends and Recent Advancement

  Jan 01, 2019  |  Published by: CBR Pharma Insights, LLC  |  USD 2,995

  ... increasing adoption of targeted therapies in the pharmaceutical industry where they invest significant capital and resources into preserving the patient’s life and the subsequent profits of products which take several years to develop. Clinical trial ... Read More

< prev 75 76 77 78 79 80 next >